| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/29/2005 | EP0735888B1 Purine compositions |
| 06/29/2005 | EP0721501B1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 06/29/2005 | CN1633506A Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 06/29/2005 | CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof |
| 06/29/2005 | CN1633440A Derivatives of branched-chain lipophilic molecules and uses thereof |
| 06/29/2005 | CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/29/2005 | CN1633309A Method of radio-labelling biomolecules |
| 06/29/2005 | CN1633308A Treatment of ophthalmic disorders using urea and urea derivatives |
| 06/29/2005 | CN1633305A Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| 06/29/2005 | CN1633304A Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 06/29/2005 | CN1633298A Novel use of 2-phenyl-substituted imidazotriazinones |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1633292A Cotherapy with an oxazolidinone and a vitamin B |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1633287A Biphenil derivatives and their use as antiandrogenic agents |
| 06/29/2005 | CN1633286A Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 06/29/2005 | CN1633285A 组合物 The composition |
| 06/29/2005 | CN1633283A Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| 06/29/2005 | CN1633280A Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
| 06/29/2005 | CN1631876A Preparation of sodium probenecid and potassium probenecid, compound injection prepared by sodium probenecid, potassium probenecid and beta-lactam antibiotics, and use thereof |
| 06/29/2005 | CN1631371A Oral administered bitter free powder of macrolide antibiotic, its prescription and preparation process |
| 06/29/2005 | CN1208126C Nano-titanium dioxide photocatalyst film, preparation and its application |
| 06/29/2005 | CN1208087C Method and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 06/29/2005 | CN1208065C Synergistic inhibition of viral replication long-chain hydrocarbons and nucleoside analogs |
| 06/28/2005 | US6911545 Crystals of glucokinase and methods of growing them |
| 06/28/2005 | US6911526 Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof |
| 06/28/2005 | US6911525 Lipopeptides as antibacterial agents |
| 06/28/2005 | US6911480 Methods for the inhibition of exoprotein production from Gram positive bacteria |
| 06/28/2005 | US6911466 Amyloid precurser protein lowering agents used in preventing, delaying, or reversing the progression of Alzheimer's disease; identifying agents that increase or decrease the risk of developing Alzheimer's disease |
| 06/28/2005 | US6911462 Benzimidazole compounds for regulating IgE |
| 06/28/2005 | US6911459 Pharmaceutical composition |
| 06/28/2005 | US6911438 Mixture of 2-hydroxyestrone and a substantially less amount of 17-beta estradiol |
| 06/28/2005 | US6911435 Method of treating leukopenia with adenosine |
| 06/28/2005 | US6911428 Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/28/2005 | US6911220 Inactivating mature recipient t cells and introducing into a primate recipient fetal or neonatal thymic tissue from a donor of a different species; restoring thymus dependent ability for progenitors to develop into mature t cells |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | US6911199 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/28/2005 | CA2402300C Fluorocarbon aerosol medicaments |
| 06/28/2005 | CA2271196C Pharmaceutical compositions of hiv protease inhibitors with improved oral bioavailability |
| 06/28/2005 | CA2232230C Phosphopantetheinyl transferases and uses thereof |
| 06/23/2005 | WO2005057588A2 Granulated decontamination formulations |
| 06/23/2005 | WO2005056804A1 Method of controlling function of receptor |
| 06/23/2005 | WO2005056789A1 Cellular membrane composition and method of preparing the same |
| 06/23/2005 | WO2005056641A1 Coordination complex of diaminocyclohexaneplatinum(ii) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 06/23/2005 | WO2005056056A2 The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
| 06/23/2005 | WO2005056027A2 Solvent for biogenic active pharmaceutical ingredients |
| 06/23/2005 | WO2005055997A1 Medicinal composition for treating and preventing inflammatory disease |
| 06/23/2005 | WO2005055963A2 Decontamination formulation with sorbent additive |
| 06/23/2005 | WO2005055956A2 Method for improving insulin sensitivity by administering an inhibitor of antitrypsin |
| 06/23/2005 | WO2005055932A2 Therapeutic combinations and methods including irm compounds |
| 06/23/2005 | WO2005055929A2 Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 06/23/2005 | WO2005055739A1 Edible compositions which are adapted for use by a companion animal |
| 06/23/2005 | WO2005046662A3 Hdl-boosting combination therapy complexes |
| 06/23/2005 | WO2005042020A3 Combinations for hcv treatment |
| 06/23/2005 | WO2005041919A3 Medicamentously targeted local lipolysis |
| 06/23/2005 | WO2005030187A3 Iloprost in combination therapies for the treatment of pulmonary arterial hypertension |
| 06/23/2005 | WO2005014584A9 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis |
| 06/23/2005 | WO2005013945A3 Medicaments for inhalation comprising steroids and a betamimetic |
| 06/23/2005 | WO2005011652A3 Use of a vitamin d receptor activator or a vitamin d analog to treat kidney disease |
| 06/23/2005 | WO2003102163A8 Methods of diagnosing and treating diabetes and insulin resistance |
| 06/23/2005 | US20050138676 Identification of genes involved in Alzheimer's disease using Drosophila melanogaster |
| 06/23/2005 | US20050137334 Composite nanospheres and their conjugates with biomolecules |
| 06/23/2005 | US20050137253 Non-alpha tocopherol such as gamma-tocopherol and an omega-3 fatty acid such as docosahexaenoic acid; e.g. end-stage renal disease, diabetes, respiratory system disorders such as asthma, lupus |
| 06/23/2005 | US20050137242 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137210 Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders |
| 06/23/2005 | US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment |
| 06/23/2005 | US20050137205 Antiinflammatory agents for treatment of skin disorders |
| 06/23/2005 | US20050137200 Potassium channel modulators; antiarrhythmia agents |
| 06/23/2005 | US20050137194 Treatment of overactive bladder with opiods |
| 06/23/2005 | US20050137176 Receptor ligands for cosmetics or skins for maintaining cutaneous homeostasis |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137159 Methods compositions and articles of manufacture for modulating bone growth |
| 06/23/2005 | US20050137158 Methods for targeting RNA molecules |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050137146 Agents for treatment of glaucomatous retinopathy and optic neuropathy |
| 06/23/2005 | US20050137144 synergistic admnistration of a weight-loss promoting anticonvulsant of of zonisamide or topiramate, and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |
| 06/23/2005 | US20050137139 Peptidomimetic compounds, useful as antiviral agents; used to inhibit HCV replication and to lessen the risk of or the severity of HCV infection |
| 06/23/2005 | US20050137137 Inhibitors of the Interaction between p53 and MDM2 |
| 06/23/2005 | US20050137125 concurrent administration of cysteamine hydrochloride with metformin |
| 06/23/2005 | US20050137124 Agents for intravitreal administration to treat or prevent disorders of the eye |
| 06/23/2005 | US20050137121 Inhibition of invasive remodelling |
| 06/23/2005 | US20050136537 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease |
| 06/23/2005 | US20050136514 Related to sodium/glucose cotransporter subfamily; drug screening; biochips; host cells |
| 06/23/2005 | US20050136502 Treatment of disorders associated with elevated blood glucose or blood pressure |
| 06/23/2005 | US20050136476 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 06/23/2005 | US20050136465 Screening assays |
| 06/23/2005 | US20050136402 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
| 06/23/2005 | US20050136141 Compositions of and derived from strawberry and raspberry and therapeutic uses thereof |
| 06/23/2005 | US20050136131 Adding glycine to a first saturated brine, evaporating the first saturated brine and glycine to obtain:crystals comprising a high content of glycine, and mother liquor;washing the crystals with a second saturated brine to obtain:rhombic dodecahedron shaped salt comprising 0.5 to 1.0% glycine |
| 06/23/2005 | US20050136130 Dietary supplements for inhibiting the progression of macular degeneration and promoting healthy vision |
| 06/23/2005 | US20050136127 Trimebutine and/or fedotozine combined with laxatives, antidiarrheals, antibiotics, antiulceratives, gastric secretion inhibitors, peristalitc stimulants, serotonin (5HT3) receptor antagonists, serotonin (5HT4) receptor agonists and/or selective serotonin reuptake inhibitors |
| 06/23/2005 | US20050136063 Anti-IGFR antibody therapeutic combinations |
| 06/23/2005 | US20050136047 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 06/23/2005 | US20050136038 Organic binder having an affinity for the calcium phosphate particles, stem cells, osteogenic cells, and/or osteoprogenitor cells, and a buffer; can be injected to repair an osseous defect |
| 06/23/2005 | US20050136037 Bacteriophage for lysis of Methylobacterium and compositions and uses thereof |
| 06/23/2005 | US20050136034 Uses of IL-12 in hematopoiesis |
| 06/23/2005 | US20050136030 with cholestyramine or colestipol; kit for treating obesity |
| 06/23/2005 | US20050136015 Applying 5-chlorosalicylic acid, 5-bromosalicylic acid for treating skin, and nail disorders, dandruff, acne, excess sebum production, enlarged skin pore size, and blackheads; cosmetics |
| 06/23/2005 | DE10356248A1 Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden A pharmaceutical composition for the treatment of rhinitis |